Phillip B. Donenberg - 16 Aug 2023 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
16 Aug 2023
Net transactions value
+$100,000
Form type
4
Filing time
16 Aug 2023, 21:51:19 UTC
Previous filing
26 Jun 2023
Next filing
31 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $100,000 +111,111 +3704% $0.9000 114,111 16 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.